Filing metadata

Accession number
0001127602-20-013334
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 06, 2020
Reporting period
Apr 02, 2020
Description
Initial ownership

Explore SEC Filings Hub